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AIM Screening for cognitive impairment, developmental delay, and neuropsychiatric
problems is not always performed in children with epilepsy. The aim of this study was to
assess the value of this screening and its validity for determining previously unidentified
(‘actionable’) problems in children with epilepsy.
METHOD New and existing patients with epilepsy were recruited from a hospital-based
epilepsy center. The parent of the child completed screening evaluations for development
(Ages and Stages Questionnaire [ASQ], 0–66mo), autism (Modified Checklist for Autism in
Toddlers [mCHAT], 16–30mo), social communication (Social Communication Questionnaire
[SCQ], ≥4y), and psychiatric concerns (Strengths and Difficulties Questionnaire [SDQ], 4–17y).
RESULTS We screened 236 children overall (136 males [58%], 100 females [42%]; mean age
[SD] 6y 7mo [4y 6mo]). Of these, 176 children (75%) had established epilepsy diagnoses and
60 (25%) were patients with new-onset epilepsy. Of those with new-onset disease, 22 (37%)
were determined not to have epilepsy. Positive findings by test were 82% (ASQ), 54%
(mCHAT), 15%, (SCQ), and 58% (SDQ). Findings were actionable in 46 children (20%): 18% of
findings in children with established epilepsy and 23% of findings in patients with new-onset
epilepsy. Of the 46 children for whom further referrals were made, the parents of 28 (61%)
have pursued further evaluations.
INTERPRETATION In this study, children with existing and new-onset diagnoses of epilepsy
had actionable screening findings. These findings support the development of systematic
screening of comorbidities for children with epilepsy.
Children with epilepsy are at a higher risk of developmen-
tal, cognitive, and behavioral difficulties that may have
consequences lasting into adulthood.1
These problems can be present at onset2,3 or develop
during the course of epilepsy, possibly in association with
the occurrence of seizures, the treatment of epilepsy, or
the possible comorbidity with epilepsy of cognitive, neuro-
developmental, and psychiatric disorders.4
While recommendations exist for routine screening for
developmental delay and autism in all infants and toddlers5
and depression in adolescents,6 adherence to these recom-
mendations has not been measured. Given that children
with epilepsy are at particularly high risk of these difficul-
ties, we sought to assess the value of a routine screening
program in our hospital-based epilepsy center.
METHOD
Patients
The parents of all patients seen in either the monitoring
unit or the ketogenic diet clinic of the epilepsy center were
asked to complete a series of screening questionnaires. The
comorbidity screening program has been part of standard
care in our center since November 2010. The patients seen
in the epilepsy monitoring unit were either established
patients of the clinic or new patients who were being eval-
uated for the first time and had not yet received a diagno-
sis of epilepsy.
Parents provided written informed consent and the chil-
dren assented as appropriate for their age and level of
development. All procedures were approved by the Ann
and Robert H Lurie Children’s Hospital of Chicago insti-
tutional review board.
Measures
Development was assessed using the Ages and Stages
Questionnaire (ASQ, age 1–66mo).7 Autism screening was
performed using the Modified Checklist for Autism in
Toddlers ([mCHAT],8 for age 16–30mo; however, use in
this study was extended to 4y) and the Social Communica-
tion Questionnaire ([SCQ],9 age ≥4y). The Strength and
Difficulties Questionnaire ([SDQ], age 4–17y) was used to
screen for mental health problems.10 All of the instruments
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selected were available and validated in English and
Spanish.
Each screening instrument used took 10 to 15 minutes
to complete. Depending on the age of the child, the com-
bination of screening questionnaires took parents 20 to 50
minutes to complete, with the majority finishing within 20
or 30 minutes. There is no financial charge for the
mCHAT and SDQ screening questionnaires, as they are
freely available on the internet. The ASQ requires a one-
time modest payment for the forms and scoring instruc-
tions, which can then be used without limitation. The
SCQ forms need to be purchased.
In our center, the screening program was carried out by
advanced practice nurses, and positive findings were
reviewed by an attending neurologist, pediatrician, or
psychiatrist. If the screening measures detected previously
unidentified concerns or problems for which a child was
not receiving services, a referral was made to psychiatry,
educational services, or specific therapeutic interventions as
appropriate. Other health professionals in the healthcare
setting, such as advanced practice nurses, physician’s assis-
tants, social workers, and psychologists, can also perform
screening. Referrals can be made by appropriate providers.
Patient medical records were subsequently reviewed for
evidence that the parents followed through with the refer-
ral recommendations.
Statistical analysis
The data were analyzed using SPSS software, version 20.0
(IBM SPSS Statistics, IBM Corp, Armonk, NY, USA).
Bivariate analyses were conducted with the v2 test, Student
t-test, or Mann–Whitney U test (for non-parametric ordi-
nal data), as appropriate for the data.
RESULTS
Sample characteristics
A total of 236 children and adolescents (136 males, 100
females) were screened in the period between November
2010 and April 2013. Of these, 176 (75%) were patients
with an established diagnosis of epilepsy or seizures and 60
children (25%) were new, screened in the new-onset epi-
lepsy clinic. After full evaluations were complete, 16 of the
60 patients in our new-onset clinic were determined not to
have epilepsy, but were found to have another disorder. In
six patients with new-onset events, the evaluation was
inconclusive. Finally, 14 children had seizures but did not
meet conventional criteria for epilepsy (recurrent unpro-
voked seizures). These children had all experienced at least
one seizure (n=6 single unprovoked seizure, n=7 recurrent
febrile seizures, and n=1 prolonged febrile seizure) and
were considered at high risk of epilepsy, as a result of a
strong family history or a neurological insult. All of these
patients were kept in our sample, as they were evaluated
for epilepsy and represented an important segment of the
children regularly seen in an epilepsy service.11
The mean age (SD) at the time of screening was 6y 7mo
(SD 4y 6mo), range 1mo–18y. Children with established
epilepsy were slightly older than those seen in the
new-onset clinic (6y 11mo [SD 4y 7mo] vs 5y 6mo [SD 4y
3mo], p=0.03) but were similar in distribution of sex (60%
and 52% male, p=0.28). Of the 214 children with diagnosis
of epilepsy or at ‘high risk’ for seizures, the mean age at
onset was 3 years 5 months (range 0–17y).
Of the children with seizures (epilepsy or high risk), 96
out of 214 (45%) had non-syndromic forms of epilepsy.
The clinical characteristics of the group, including specific
epilepsy syndromes, are provided in Table I.
Screening results
Overall, of the 236 children participating in this program,
100 were assessed using the ASQ, 69 using the mCHAT,
139 using the SCQ, and 96 using the SDQ. Positive
screening results were obtained for developmental delay
(ASQ) in 82 out of 100 (82%), for autism in 37 out of 69
(54%) on mCHAT and 21 out of 139 (15%) on SCQ, and
for behavioral and psychiatric concerns (SDQ) in 56 out of
96 (58%) patients. The screening results and their associa-
tion with clinical characteristics of the children are
presented in Table I.
Patients with established epilepsy were more likely than
new-onset patients (all combined) to screen positive for
developmental delay (88% vs 65%, p=0.01), autism (62%
vs 29%, p=0.02 for mCHAT, 20% vs 0%, p=0.002 for
SCQ), and behavioral–psychiatric concerns (64% vs 39%,
p=0.03).
Among children aged 4 years and older, the patients
with established epilepsy were more likely than those with
new-onset epilepsy to show evidence of autism on the
SCQ (77% vs 23%, p<0.001), and similarly for behavioral–
psychiatric concern on the SDQ (76% vs 24%, p=0.03; see
Table II). The SDQ was completed for 96 children (73
with established epilepsy, 23 with new-onset epilepsy). In
each of the six domains, established patients had the high-
est yield (Table III).
Autism screening results relative to developmental,
behavioral, and psychiatric screening
Positive autism screening results were associated with a
clinical diagnosis of autism more often for screening per-
formed with the SCQ (12 out of 21 patients, 57%), than
with the mCHAT (3 out of 37 patients, 8%; p<0.001).
Cognitive and developmental disabilities were also more
common in children who screened positive for autism than
in those who did not (57% vs 19%, p<0.001). Of the chil-
dren who screened positive and were actually diagnosed
with autism (n=15), 12 also had developmental delays or
intellectual disability.
What this paper adds
• Actionable results were found in 20% of children with epilepsy who were
screened.
• Routine screening should be offered to all children with established or new-
onset epilepsy.
• Screening should be done in conjunction with a capacity for referral, in
order to interpret and act on the results.
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‘Actionable’ findings
Overall, tests revealed evidence of problems that required
additional referral or evaluation (‘actionable’; see Table IV)
in 46 (20%) of the 236 patients who were screened.
Actionable findings occurred in comparable proportions of
established patients (n=32, 18%) and patients seen in the
new-onset clinic setting (n=14, 23%, p=0.26).
Actionable findings were found in 21 children (21%)
who were screened for developmental delay using the
ASQ. The comparable figures for the other questionnaires
were 15 (22%) on mCHAT and 25 (18%) on SCQ for aut-
ism, and 18 patients (19%) on the SDQ for behavioral–
psychiatric concerns. The proportion of patients with
actionable findings was similar in the subgroup of children
who were found not to have epilepsy (n=5, 23%) and in
the subgroup of children with ‘high risk’ of seizures (n=2/
14, 14%).
Types of referral made for children with actionable
findings
Of the 46 children with actionable screening results, 44
(19%) were referred to psychiatric, psychological, or edu-
cational specialists, five (2%) were referred back to the
neurologist or pediatrician, and 21 (7%) were referred to
specific therapeutic interventions (e.g. physical, speech, or
occupational therapy, or early intervention programs).
Some children received multiple referrals (Table SI, online
supporting information). To date, and based on the
records available, at least 28 children (61%) have followed
through on referral recommendations (Table IV).
DISCUSSION
In our hospital-based epilepsy center, we found a very high
yield of developmental and behavioral concerns as assessed
by standard screening tools. Furthermore, screening
revealed evidence of problems that had not been previously
recognized in some children. These resulted in referrals to a
variety of resources in one of every five patients screened in
our program. This report, which covers children and adoles-
cents from 0 to 18 years of age, provides a substantial
update from a previous preliminary report carried out at the
center of the first 66 young patients in our program.12 The
wider sample of patients obtained means that this research
also includes children aged 4 years and older, which the
previous study did not.
Research has demonstrated that developmental attain-
ment is maximized and can have lifelong benefits when
intervention is initiated earlier, and that such programs are
Table I: Positive findings on screening instruments for patients with established and new-onset epilepsy and the results of epilepsy diagnosis by scre-
ening results and by age of the child (<5y vs ≥5y)
Ages and Stages
Questionnaire
(n=100), n (%)
Modified Checklist
for Autism in Toddlers
(n=69), n (%)
Social Communication
Questionnaire
(n=139), n (%)
Strengths and
Difficulties
Questionnaire
(n=96), n (%)
Overall (n=236) 82 (82) 37 (54) 21 (15) 56 (58)
Established epilepsy (n=176) 65/74 (88) 32/52 (62) 21/106 (20) 47/73 (64)
New-onset epilepsy (n=60) 17/26 (65) 5/17 (29) 0/32 (0) 9/23 (39)
p 0.014 0.021 0.002 0.029
Male (n=136, 58%) 62 (62) 43 (62) 79 (57) 51 (53)
Female (n=100, 42%) 38 (38) 26 (38) 60 (43) 45 (47)
p 0.433 0.439 0.226 0.127
Type of epilepsy
Non-syndromic epilepsy with
focal features (n=60, 25%)
9 (15) 10 (17) 49 (82) 21 (35)
Non-syndromic epilepsy with
generalized features (n=36, 15%)
7 (19) 6 (17) 30 (83) 13 (36)
Infantile spasms (n=29, 12%) 28 (97) 18 (62) 2 (7) 1 (3)
Epileptic encephalopathiesa
(n=16, 7%)
12 (75) 10 (63) 6 (38) 5 (31)
Absence epilepsyb (n=14, 6%) 6 (43) 3 (21) 10 (71) 3 (21)
Myoclonic absence epilepsy
(n=15, 6%)
0 6 (40) 6 (40) 1 (7)
Benign seizure susceptibility
syndrome (n=20, 9%)
1 (5) 2 (10) 16 (80) 5 (25)
Epilepsy not otherwise
specifiedc (n=3, 1%)
1 (33) 1 (33) – 1 (33)
High riskd (n=14, 6%) 7 (50) 7 (50) 5 (36) 2 (14)
Non-conclusivee (n=6, 3%) 2 (33) 2 (33) 3 (50) 1 (17)
Not epilepsyf (n=16, 7%) 6 (35) 3 (18) 9 (53) 1 (6)
Subgroup by age
<4y (n=78) 63/67 (82) 29/58 (50)
≥4y (n=157) 19/23 (83) 5/11 (46) 26/132 (19) 56/96 (58)
p 0.601 0.521 0.303
aIncluding Lennox–Gastaut syndrome. bIncluding childhood absence epilepsy. cIncluding unclassified. dPatients with a history of unpro-
voked single or several seizures, such as febrile seizure, that had not developed as epilepsy yet. eExaminations for diagnosis are still
ongoing and not proved yet. fDiagnosis could not be determined.
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cost-effective.13 Randomized evaluations of early interven-
tion programs have demonstrated the beneficial impact of
such interventions in children who are socially or biologi-
cally at risk of developmental delay, especially in tradi-
tional measures of development, such as cognitive, motor,
and social–emotional skills.14–16
This has led professional societies, such as the American
Academy of Pediatrics (AAP), to recommend that screening
be performed for all young children at risk using screening
instruments such as those used in this study (mCHAT and
ASQ).5 The American Academy of Neurology and the
Child Neurology Society also recently published recom-
mendations for developmental screening tools with good
sensitivity and specificity to be used at every preventive
visit.17,18 In the case of older children (12–18y), the US
Preventive Services Task Force (USPSTF) recommends
screening for depression.6 Such a recommendation is espe-
cially important given the evidence concerning the higher
risk of psychiatric disorders in children with epilepsy.
In light of the well-known burden of cognitive, behav-
ioral, and psychiatric disorders in children with epilepsy,
and given the recommendations for screening in primary
care from various professional groups,5 it is noteworthy
that so many children in our study had actionable findings.
This raises the question of whether these children had pre-
viously received routine screening in either the primary or
neurological care settings. Even if they had, there may be a
need for repeated screening over time to monitor for
changes in behavior or development.
There has been much concern regarding the association
between epilepsy and autism.19,20 A previous report found
a high yield of autism using the mCHAT in children with
refractory epilepsy. This study is sometimes used as evi-
dence of the high prevalence of autism in children with
epilepsy; however, it did not report on actual autism diag-
nosis or take into account level of intellectual disability.20
Autism screening is not the same as diagnosis. Autism is a
complex disorder and the diagnostic evaluation requires
assessment of the individual’s cognitive and adaptive levels,
as well as the features of autism.21 The mCHAT, in partic-
ular, while a popular and helpful screening tool, must be
interpreted very carefully, as many of the items used to
indicate autistic features, including the critical items, are
also signs of neurological impairment (e.g. vision or hear-
ing impairment), and others are non-specific symptoms of
global delay.22
Thus, any positive autism screening result must be inter-
preted in light of the child’s developmental and neurologi-
cal status. Although screening of children for
developmental delay, autism, and other behavioral difficul-
ties is increasingly accepted as a core element of general
pediatric practice,5 it may not always be feasible. Develop-
mental screening programs take time and effort to admin-
ister. A recent cost–benefit analysis of developmental
Table II: Positive screening results on the Social Communication Ques-
tionnaire and Strengths and Difficulties Questionnaire and clinical vari-
ables for children aged ≥4 years or more (n=157)
Social
Communication
Questionnaire
(n=139), n (%)
Strengths and
Difficulties
Questionnaire
(n=96), n (%)
Overall positive screening 26 (19) 56 (58)
Sex
Male (n=89) 78 (57) 51 (53)
Female (n=68) 60 (44) 45 (47)
p 0.226 0.127
Type of patient
Established (n=121) 106 (77) 73 (76)
New-onset (n=36) 32 (23) 23 (24)
p <0.001 0.029
Type of epilepsy
NSE with focal
features (n=52)
49 (94) 36 (69)
NSE with generalized
features (n=29)
29 (100) 19 (66)
Infantile spasms (n=4) 2 (50) 1 (25)
Epileptic encephalopathiesa
(n=8)
6 (75) 5 (63)
Absence epilepsyb (n=12) 10 (83) 9 (75)
Myoclonic absence
epilepsy (n=10)
6 (60) 5 (50)
BCSSS (n=18) 16 (89) 9 (50)
Epilepsy NOSc (n=3) 0 (0) 1 (33)
High riskd (n=5) 5 (100) 3 (60)
Non-conclusivee (n=3) 3 (100) 2 (67)
Not epilepsyf (n=9) 9 (100) 4 (44)
Age at onset (y)
<10 (n=94) 18/79 (23) 31/50 (62)
≥10 (n=63) 8/59 (14) 25/46 (54)
p 0.124 0.290
aIncluding Lennox–Gastaut syndrome. bIncluding childhood
absence epilepsy. cIncluding unclassified. dPatients with history of
unprovoked single or several seizures, such as febrile seizure, but
who had not developed as epilepsy yet. eExaminations for diagno-
sis are still ongoing and not proved yet. fDiagnosis could not be
determined. NSE, nonsyndromic epilepsy; BCSSS, benign child-
hood seizure susceptibility syndrome; NOS, not otherwise
specified.
Table III: Screening yield for the Strengths and Difficulties Questionnaire
No. of positive results per domain
Total patients
(n=96), n (%)
Established
patients (n=73), n (%)
New-onset patients
(n=23), n (%) p
Overall stress 35 (37) 30 (41) 5 (22) 0.073
Emotional distress 23 (24) 18 (25) 5 (22) 0.508
Behavioral difficulties 20 (21) 17 (23) 3 (13) 0.228
Hyperactivity/attention difficulties 31 (32) 27 (37) 4 (17) 0.064
Difficulty getting along with other children 27 (28) 23 (32) 4 (17) 0.147
Kind and helpful behavior 33 (34) 28 (38) 5 (22) 0.111
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screening approaches, including costs of administration,
interpreting results, diagnostic testing, and treatment,
showed that the use of parental reports was by far the most
efficient approach.23 Advanced practice nurses, physician’s
assistants, social workers, and psychologists, as certified
professionals, can perform a screening program and appro-
priate providers can make referrals in other healthcare set-
tings. Other considerations also play a role, including the
parent’s time, parent’s health literacy, scoring and report-
ing, and referral resources when further evaluations are
needed.
Our study has several limitations. As we screened
patients in the epilepsy monitoring unit and ketogenic diet
clinic, parents were often at the hospital for prolonged or
multiple appointments and had time to complete the
screening questionnaires. Implementing our program more
broadly, including in the outpatient setting, may require
more modifications.
Our findings may over represent the yield of screening
in children with epilepsy, as our study was based in a ter-
tiary center. While that may be the case, population-based
studies all demonstrate a very high level of intellectual dis-
ability (20–25%) in children who developed epilepsy within
the first 15 years of life.24,25 Among patients who develop
epilepsy at a younger age, the proportion is even higher.24
Thus, regardless of whether or not the yield might be
somewhat lower in the general population, we have good
reason to believe that it is still relatively high and warrants
a systematic approach to identify these difficulties at the
earliest possible opportunity. We also had limited ability
to determine whether parents had followed through on
referral recommendations. Thus, it is likely that our find-
ing that 61% parents followed through with referrals
underestimates how many really did pursue further evalua-
tions.
Our study lays the foundation for future studies to con-
tinue to improve the early identification of epilepsy and its
comorbid health conditions.26 The implementation of
screening will require an understanding of the reasons why
children do not currently receive routine screening. Solu-
tions will need to be identified to overcome those barriers.
An alternative briefer screening approach is one strategy
that we are currently developing. Systems that would allow
parents to directly input information and then score the
survey and provide a report for staff would make screening
far more feasible and greatly reduce the time and resources
required from physicians and staff. We are aware of one
such system, the Child Health and Development Interac-
tive System (CHADIS; www.chadis.com), which provides
these services for an annual fee. Other possibilities include
designing, building, and maintaining an internal system. In
any case, it is likely that quality of care indicators would
encompass measures such as developmental, behavioral,
and psychiatric screening in the near future. The yield in
children with epilepsy certainly warrants that screening be
adopted. Whether screening should be done in the primary
care or the neurology setting may not always be clear;
however, this is certainly an issue that would benefit from
discussion among the interested parties.
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